Ep188: Art Krieg on Innate Immune System Activators for Cancer episode artwork

EPISODE · Oct 28, 2025 · 1H 9M

Ep188: Art Krieg on Innate Immune System Activators for Cancer

from The Long Run with Luke Timmerman · host Timmerman Report

Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.

Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.

NOW PLAYING

Ep188: Art Krieg on Innate Immune System Activators for Cancer

0:00 1:09:05

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Long Run with Luke Timmerman?

This episode is 1 hour and 9 minutes long.

When was this The Long Run with Luke Timmerman episode published?

This episode was published on October 28, 2025.

What is this episode about?

Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.

Can I download this The Long Run with Luke Timmerman episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!